Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Free Report) – Investment analysts at Brookline Capital Management cut their Q2 2024 earnings per share estimates for shares of Bioceres Crop Solutions in a research note issued on Tuesday, November 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings of $0.09 per share for the quarter, down from their previous forecast of $0.11. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.69 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q3 2024 earnings at $0.38 EPS.
Several other equities research analysts have also weighed in on BIOX. Roth Mkm reduced their target price on Bioceres Crop Solutions from $31.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, November 1st. Lake Street Capital cut their price target on Bioceres Crop Solutions from $30.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, September 12th.
Bioceres Crop Solutions Stock Down 2.7 %
BIOX opened at $11.36 on Thursday. The business has a 50 day moving average price of $10.87 and a 200 day moving average price of $11.70. Bioceres Crop Solutions has a twelve month low of $9.76 and a twelve month high of $14.20. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.86 and a current ratio of 1.33. The firm has a market cap of $719.43 million, a P/E ratio of 63.11 and a beta of 0.45.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its earnings results on Monday, September 11th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.10). Bioceres Crop Solutions had a return on equity of 3.42% and a net margin of 2.71%. The company had revenue of $104.70 million during the quarter, compared to analyst estimates of $96.59 million. During the same quarter last year, the firm posted ($0.12) earnings per share.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the business. Advisor Group Holdings Inc. increased its position in shares of Bioceres Crop Solutions by 66.9% during the fourth quarter. Advisor Group Holdings Inc. now owns 2,242 shares of the company’s stock valued at $27,000 after purchasing an additional 899 shares during the period. Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions during the fourth quarter valued at approximately $49,000. LGT Fund Management Co Ltd. bought a new stake in shares of Bioceres Crop Solutions during the second quarter valued at approximately $134,000. Goldman Sachs Group Inc. bought a new stake in shares of Bioceres Crop Solutions during the second quarter valued at approximately $176,000. Finally, Sei Investments Co. bought a new stake in shares of Bioceres Crop Solutions during the second quarter valued at approximately $221,000. 13.35% of the stock is currently owned by institutional investors and hedge funds.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition.
- Five stocks we like better than Bioceres Crop Solutions
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Amazon, Target, Walmart in a race for fastest delivery
- The Role Economic Reports Play in a Successful Investment Strategy
- Palo Alto Networks: the one security stock to rule them all
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Is it time to buy the dip in Walmart shares?
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.